Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

RegeneRx Biopharmaceuticals, Inc. RGRX

Full chart Compare
Set alert

Price alert · RGRX

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.161 Day range 0.161
0.0002 52-week range 0.163
YTD
+266.67%
1 year
-99.32%

Financial health

Altman Z-Score

-878.30 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -13.9×
FY 2013: -652×FY 2014: -488×FY 2015: -848×FY 2016: 15110×FY 2017: 6296×FY 2018: -939×FY 2019: -1176×FY 2020: -3702×FY 2021: -1151×FY 2022: -13.9×
FY 2013 5y median -1151× FY 2022
P/S 25976×
FY 2013: 14831×FY 2014: 0.0×FY 2015: 73702×FY 2016: 36314×FY 2017: 32241×FY 2018: 26858×FY 2019: 23887×FY 2020: 84259×FY 2021: 28888×FY 2022: 25976×
FY 2013 5y median 26858× FY 2022
P/B -579×
FY 2013: -270×FY 2014: -784×FY 2015: -663×FY 2016: -559×FY 2017: -444×FY 2018: -846×FY 2019: -784×FY 2020: -2290×FY 2021: -994×FY 2022: -579×
FY 2013 5y median -846× FY 2022
P/FCF -2120×
FY 2013: -559×FY 2014: -781×FY 2015: -8486×FY 2016: -3172×FY 2017: -2755×FY 2018: -2106×FY 2019: -1611×FY 2020: -6423×FY 2021: -2239×FY 2022: -2120×
FY 2013 5y median -2120× FY 2022
EV/EBITDA -221673881×
FY 2013: -775×FY 2014: -865×FY 2015: -877×FY 2016: 8350×FY 2017: 3268×FY 2018: -983×FY 2019: -1468×FY 2020: -5016×FY 2021: 39946×FY 2022: -221673881×
FY 2013 5y median -1468× FY 2022
EV/Sales 25991×
FY 2013: 14845×FY 2014: 0.0×FY 2015: 73708×FY 2016: 36314×FY 2017: 32249×FY 2018: 26855×FY 2019: 23888×FY 2020: 84267×FY 2021: 28887×FY 2022: 25991×
FY 2013 5y median 26855× FY 2022
FCF Yield -0.0%
FY 2013: -0.2%FY 2014: -0.1%FY 2015: -0.0%FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.0%FY 2019: -0.1%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.0%
FY 2013 5y median -0.0% FY 2022

Profitability

Gross Margin 100.0%
FY 2013: 99.4%FY 2014: 0.0%FY 2015: 99.7%FY 2016: 99.7%FY 2017: 94.6%FY 2018: 99.9%FY 2019: 99.9%FY 2020: 93.6%FY 2021: 91.4%FY 2022: 100.0%
FY 2013 5y median 99.9% FY 2022
Operating Margin -1826.4%
FY 2013: -3100.0%FY 2014: 0.0%FY 2015: -2821.2%FY 2016: -1794.1%FY 2017: -2550.7%FY 2018: -1899.0%FY 2019: -1644.0%FY 2020: -1687.1%FY 2021: -1731.3%FY 2022: -1826.4%
FY 2013 5y median -1731.3% FY 2022
Net Margin -2249.8%
FY 2013: -2275.8%FY 2014: 0.0%FY 2015: -8694.6%FY 2016: 245.6%FY 2017: 505.7%FY 2018: -2862.2%FY 2019: -1829.0%FY 2020: -1984.1%FY 2021: -2081.8%FY 2022: -2249.8%
FY 2013 5y median -2081.8% FY 2022
ROE 50.1%
FY 2013: 41.4%FY 2014: 160.9%FY 2015: 78.2%FY 2016: -3.8%FY 2017: -7.0%FY 2018: 90.1%FY 2019: 60.0%FY 2020: 53.9%FY 2021: 71.7%FY 2022: 50.1%
FY 2013 5y median 60.0% FY 2022
ROIC 1094.4%
FY 2013: 159.4%FY 2014: -288.2%FY 2015: 209046.5%FY 2016: -333.0%FY 2017: 80.5%FY 2018: -6364.2%FY 2019: -254.3%FY 2020: -570.9%FY 2021: -150.5%FY 2022: 1094.4%
FY 2013 5y median -254.3% FY 2022
ROA -451.9%
FY 2013: -1570.3%FY 2014: -290.1%FY 2015: -1471.2%FY 2016: 26.6%FY 2017: 126.2%FY 2018: -709.5%FY 2019: -197.3%FY 2020: -276.0%FY 2021: -124.4%FY 2022: -451.9%
FY 2013 5y median -276.0% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: -97.8%FY 2014: -100.0%FY 2015: 0.0%FY 2016: 53.9%FY 2017: -39.3%FY 2018: 23.0%FY 2019: 10.2%FY 2020: -0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income -5.5%
FY 2013: -8.6%FY 2014: -70.1%FY 2015: -10.0%FY 2016: 2.1%FY 2017: 13.7%FY 2018: 8.4%FY 2019: 4.6%FY 2020: -2.6%FY 2021: -2.6%FY 2022: -5.5%
FY 2013 FY 2022
EPS (diluted) -7094.2%
FY 2013: 21.2%FY 2014: -259.8%FY 2015: -75.9%FY 2016: 446.8%FY 2017: -98.7%FY 2018: -787.5%FY 2019: 27.9%FY 2020: -10.1%FY 2021: -6.1%FY 2022: -7094.2%
FY 2013 FY 2022
Free Cash Flow 5.0%
FY 2013: -185.1%FY 2014: -119.7%FY 2015: 69.3%FY 2016: -102.9%FY 2017: 37.9%FY 2018: -34.0%FY 2019: -28.1%FY 2020: 11.5%FY 2021: 1.7%FY 2022: 5.0%
FY 2013 FY 2022

Financial Health

Current Ratio 0.6×
FY 2013: 0.1×FY 2014: 2.3×FY 2015: 1.0×FY 2016: 1.3×FY 2017: 0.1×FY 2018: 0.9×FY 2019: 2.8×FY 2020: 1.2×FY 2021: 2.9×FY 2022: 0.6×
FY 2013 5y median 1.2× FY 2022
Quick Ratio 0.6×
FY 2013: 0.1×FY 2014: 2.3×FY 2015: 1.0×FY 2016: 1.3×FY 2017: 0.1×FY 2018: 0.9×FY 2019: 2.8×FY 2020: 1.2×FY 2021: 2.9×FY 2022: 0.6×
FY 2013 5y median 1.2× FY 2022
Debt / Equity -0.4×
FY 2013: -0.3×FY 2014: -0.3×FY 2015: -0.1×FY 2016: -0.1×FY 2017: -0.2×FY 2018: -0.0×FY 2019: -0.3×FY 2020: -0.4×FY 2021: -0.5×FY 2022: -0.4×
FY 2013 5y median -0.4× FY 2022
Net Debt / EBITDA -128381×
FY 2013: -0.8×FY 2014: 0.2×FY 2015: -0.1×FY 2016: 0.1×FY 2017: 0.8×FY 2018: 0.1×FY 2019: -0.1×FY 2020: -0.5×FY 2021: -1.2×FY 2022: -128381×
FY 2013 5y median -0.5× FY 2022
Interest Coverage -4.3×
FY 2013: -9.1×FY 2014: -8.5×FY 2015: -9.9×FY 2016: -9.7×FY 2017: -8.5×FY 2018: -15.2×FY 2019: -8.2×FY 2020: -5.6×FY 2021: -4.1×FY 2022: -4.3×
FY 2013 5y median -5.6× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31